Related coverage linked through entity extraction aliases.
Jul 09, 2026
Biogen marked 30 years of U.S. manufacturing with a $2 billion RTP investment, while regional leaders urged deeper venture capital and research density to boost North Carolina's biotech competitiveness.
Mar 14, 2026
Ultrasound-activated bubbles show promise for cancer therapy. Duke's SonoPIN killed 50% of cancer cells, while Case Western nanobubbles broke down tumor barriers, enabling potential trials in two years.
Jul 22, 2026
Recent Rethinking Clinical Trials Grand Rounds sessions covered the COMPARE-Pediatric IBD study, a hypertension self-management texting intervention for Black Veterans, and the upcoming Pediatric Trials Network presentation.
Jun 09, 2026
A world-first clinical trial testing immunotherapy for glioblastoma has opened in the US. The GIANT trial will evaluate Nivolumab and Relatlimab before surgery, with results expected in about two years. Three patients have been enrolled so far.
Mar 24, 2026
HHS Secretary Robert F. Kennedy Jr. announces major reorganization centralizing department operations under CMS leadership, while Duke University telehealth program shows 66% reduction in repeat ER visits for older adults who fall.
Mar 11, 2026
Researchers at Duke University discovered that specialized immune cells called resident macrophages maintain the eye's drainage system and regulate pressure, potentially providing a new therapeutic target for glaucoma treatment beyond current symptom management approaches.
Feb 13, 2026
A study of 434 toddlers found no association between maternal mRNA COVID-19 vaccination during or shortly before pregnancy and autism or other neurodevelopmental disorders in offspring aged 18-30 months.
